phenyl acetate has been researched along with Premature Birth in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goto, M; Hatakeyama, S; Kosaki, R; Murashima, A; Nagase, S; Ogura, J; Takahashi, K; Tsutsumi, S; Watanabe, N; Yakuwa, N; Yamaguchi, H; Yamamoto, A; Yamane, R | 1 |
| Alfonso Martin, C; Alkhader, LF; Batalle, D; Cai, V; Dimitrova, R; Edwards, AD; Fernandes, C; Goikolea-Vives, A; Gressens, P; Hammond, B; Kislitsyna, E; Sewell, AL; Skaland, A; Stolp, HB; Thornton, C; Yates, AG; Zhang, J | 1 |
| Amabebe, E; Anumba, DOC | 1 |
3 other study(ies) available for phenyl acetate and Premature Birth
| Article | Year |
|---|---|
The safety of pranlukast and montelukast during the first trimester of pregnancy: A prospective, two-centered cohort study in Japan.
Topics: Abortion, Spontaneous; Acetates; Chromones; Cohort Studies; Cyclopropanes; Female; Humans; Infant, Newborn; Japan; Leukotriene Antagonists; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, First; Premature Birth; Prospective Studies; Quinolines; Sulfides | 2022 |
Montelukast reduces grey matter abnormalities and functional deficits in a mouse model of inflammation-induced encephalopathy of prematurity.
Topics: Acetates; Animals; Brain Diseases; Disease Models, Animal; Female; Gray Matter; Humans; Infant, Newborn; Inflammation; Male; Mice; Premature Birth; Quinolines | 2022 |
A Combination of Cervicovaginal Fluid Glutamate, Acetate and D-Lactate Identified Asymptomatic Low-Risk Women Destined to Deliver Preterm: a Prospective Cohort Study.
Topics: Acetates; Adult; Cervix Uteri; Female; Glutamic Acid; Humans; Hydrogen-Ion Concentration; Lactic Acid; Predictive Value of Tests; Pregnancy; Premature Birth; Prospective Studies; Vagina | 2022 |